Navigation Links
deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
Date:10/11/2007

REYKJAVIK, Iceland, Oct. 11 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced the launch of deCODE MI(TM), a reference laboratory test for variations in the genome (called SNPs) that the company has associated with increased risk of myocardial infarction, or heart attack. The SNPs are located on chromosome 9 and were discovered by deCODE earlier this year. As described in the journal Science in July, deCODE scientists found that people who carry two copies of these variants are at double the risk of suffering an early heart attack -- before the age of 50 in men and 60 in women -- than are those who do not carry them. deCODE validated the role of these variants in five groups of patients and controls from Iceland and the United States, and other researchers have replicated this finding in several European, US, and Canadian cohorts.

"With the launch of deCODE MI, we have taken another of our breakthroughs in genetics and transformed it into a new tool in the fight to prevent heart attack. While many risk factors for heart attack are understood, the disease remains the leading cause of death in the industrialized world and the early- onset cases often take both patients and doctors so dangerously by surprise. deCODE MI(TM) tests for a genetic risk factor that is independent of other risks such as cholesterol, obesity and smoking, and therefore provides a means of identifying individuals who may derive particular benefit from earlier and more aggressive prevention efforts," said Dr. Kari Stefansson, CEO of deCODE.

How to order deCODE MI(TM)

deCODE MI(TM) is performed in deCODE's Clinical Laboratory Improvement Amendments (CLIA) certified laboratory, and must be authorized by a qual
'/>"/>

SOURCE deCODE genetics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
2. deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
5. New Study Results Provide Additional Data about Short- and Long-Term Use of Desvenlafaxine Succinate in the Treatment of Adults with Major Depressive Disorder
6. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
7. Six-Week Investigational Study In Adults With Major Depressive Disorder Evaluates The Effectiveness of Adjunctive Aripiprazole Therapy With Antidepressants
8. Major Manufacturer of Unapproved and Adulterated Drugs
9. Exforge Helps Vast Majority of Patients Effectively Control Their Blood Pressure After Failing on Other Medicines, According to New Clinical Data
10. CuraGen and TopoTarget Announce New Clinical Results With Belinostat to be Reported at Upcoming Major Medical Meetings
11. Introgen Presents ADVEXIN Biomarker Data at Major Cancer Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... NEW YORK , March 30, 2015  Check-Cap ... diagnostics company focused on the development of a preparation-free ... screening for colorectal cancer, announced today that its CEO, ... the March 31, 2015 trading day.  Neev and Check-Cap ... to commemorate the company,s initial public offering and simultaneous ...
(Date:3/30/2015)... and ORANGEBURG, N.Y., March 30, 2015 /PRNewswire/ ... (NASDAQ: VSCI ) shareholders have voted at ... today to approve the previously announced agreement and ... "We are pleased with the outcome of ... thank both shareholder groups for approving the merger ...
(Date:3/30/2015)... , March 30, 2015  Rigrodsky & Long, P.A.: ... (NASDAQ GM: ASPX )? , Did you purchase ... , Do you think the proposed buyout price is too ... Rigrodsky & Long, P.A. announces ... of directors of Auspex Pharmaceuticals, Inc. ("Auspex" or the "Company") ...
Breaking Medicine Technology:Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 2Check-Cap to Celebrate Initial Public Offering with NASDAQ Closing Bell Ceremony on March 31, 2015 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 2Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 3Uroplasty and Vision-Sciences Shareholders Approve Merger Agreement 4AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2
... Brain Resource, Ltd., (BRRZY: OTC US, BRC: ASX), developer of ... a personal heart rate monitor for managing stress, at Health 2.0 ... slow breathing at a personal best breathing rate. ... the best ways to decrease stress, but not many people know ...
... 27, 2011 Kinerase, an icon of scientific skincare development, ... in a row.  The Kinerase Restructure Firming ... 2011 Allure Best of Beauty Awards, appearing in the magazine,s ... This year, over 236 beauty products were chosen ...
Cached Medicine Technology:Brain Resource Launches MyCalmBeat Personal Stress Reduction Monitor at Health 2.0 2Brain Resource Launches MyCalmBeat Personal Stress Reduction Monitor at Health 2.0 3Kinerase Wins Allure Best of Beauty Award for 2nd Consecutive Year 2
(Date:3/30/2015)... On March 27th, 2015, 24Hr HomeCare ... inspire courage in Seth Lane, a five-year-old boy from ... SCID causes affected individuals to be susceptible to life-threatening ... allow the development of functional immune systems. Lane, ... video with his family requesting its viewers to wear ...
(Date:3/30/2015)... March 30, 2015 GenSight ®, ... is named as a leader in The Forrester Wave™: ... 2015 report. , The independent report positions GenSight as ... possible (5 out of 5) for the analytics, corporate ... which contributed to GenSight’s position in the Leaders category. ...
(Date:3/30/2015)... 2015 V/NO (Virtually No Alcohol) Wines have ... for opening/closing and for reuse. Consumers simply twist the cup, ... New Yorkers, professionals, and basically anyone can now enjoy a ... kick back socially or pair with meals at work, home, ... dealcoholized wine and that means Napa Wine grapes undergo ...
(Date:3/30/2015)... The “Orthopedic Software Market [By ... By Applications (Orthopedic Surgery, Joint Replacement, Fracture ... – Global Forecast to 2020” analyzes and ... in North America, Europe, Asia-Pacific and the ... before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=94720371 , This ...
(Date:3/30/2015)... TX (PRWEB) March 30, 2015 ... been Drummond Certified™ in the second AS4 test ... Inc., the trusted leader in interoperability software testing. ... Oracle and Software AG participated in this vendor-neutral ... represents the first AS4 interoperability certifications for IBM, ...
Breaking Medicine News(10 mins):Health News:24Hr HomeCare Staff Hosts #WearYellowForSeth Campaign for Five-Year-Old Boy with Severe Combined Immunodeficiency 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 2Health News:GenSight Named as a Leader by Independent Research Firm in the Strategic Planning Market 3Health News:Napa Valley Alcohol-Removed Red, White & Rosé Wines Have Launched. 2Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 2Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 3Health News:The Global Orthopedic Software Market is Expected to Reach $308.5 Million by 2020 – Report Published by MarketsandMarkets 4Health News:Latest AS4 Standard-Based Products Drummond Certified™ 2Health News:Latest AS4 Standard-Based Products Drummond Certified™ 3
... By Amanda Gardner HealthDay Reporter , WEDNESDAY, Dec. ... urged the agency to take a new look at data ... include mercury. The FDA had ruled in 2009 that ... "We need to see where the science is and if ...
... HealthDay Reporter , THURSDAY, Dec. 16 (HealthDay News) ... missing amygdala -- the part of the brain believed ... help improve treatment for post-traumatic stress disorder (PTSD) ... human study confirming that the almond-shaped structure is crucial ...
... children, their families, artists and scientists in a first ... symbiosis was established between several groups in society, leading ... Ferreira, group leader at the Instituto Gulbenkian de Cincia, ... the 10,000 euros Simbiontes Award, for his proposal to ...
... NY, December 15, 2010 There is burgeoning public ... including cardiovascular health. In a study published in the ... Medicine, investigators found that there was no independent ... hormone and cardiovascular mortality in this prospective study, the ...
... WEDNESDAY, Dec. 15 (HealthDay News) -- In a rare case, a ... longer has any detectable HIV cells in his blood following a ... But experts were quick to caution that the case does not ... As it turns out, the donor for that transplant carried a ...
... WEDNESDAY, Dec. 15 (HealthDay News) -- A ban on drop-side ... of recalls and the deaths of more than 30 infants ... by the U.S. Consumer Product Safety Commission forbids the manufacture, ... rail that moves up and down. The requirement that all ...
Cached Medicine News:Health News:FDA Panel Calls for Safety Review of Mercury in Dental Fillings 2Health News:FDA Panel Calls for Safety Review of Mercury in Dental Fillings 3Health News:Brain Anomaly Leaves Woman Without Fear 2Health News:Brain Anomaly Leaves Woman Without Fear 3Health News:Instituto Gulbenkian de Ciencia scientist wins new Portuguese award Simbiontes for cancer research 2Health News:Vitamin D and parathyroid hormone levels may not affect cardiovascular mortality 2Health News:Docs Claim Transplant Cured Man of HIV, But Experts Urge Caution 2Health News:Docs Claim Transplant Cured Man of HIV, But Experts Urge Caution 3Health News:U.S. Government Bans Drop-Side Cribs 2
... Roches patented polymerase chain reaction (PCR) technology, ... is an essential component of Roches blood ... allows minute amounts of selected unique regions ... billions of copies (that is, to detectable ...
... Continuing to lead the market in ... WAVE IABP is a whole new first ... optic technology coupled with a physiologically based ... support with unprecedented timing accuracy. Second ...
... NexES IHC, the worlds first ... staining system introduced a whole ... while combining system modularity and ... laboratory productivity. The NexES Systems ...
... a nonprofit, physician-directed organization promoting quality ... care through programs of voluntary education, ... professionals in all sizes of medical ... accreditation, quality management services, consultation in ...
Medicine Products: